American Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.02M | Hold |
66,915
| – | – | 0.23% | 50 |
|
|
2026
Q1 | $3.77M | Sell |
66,915
-7,500
| -10% | -$488K | 0.2% | 54 |
|
|
2025
Q4 | $5.96M | Hold |
74,415
| – | – | 0.26% | 45 |
|
|
2025
Q3 | $3.63M | Sell |
74,415
-26,500
| -26% | -$1.64M | 0.14% | 52 |
|
|
2025
Q2 | $7.53M | Hold |
100,915
| – | – | 0.31% | 44 |
|
|
2025
Q1 | $6.41M | Buy |
100,915
+20,920
| +26% | +$1.42M | 0.26% | 46 |
|
|
2024
Q4 | $6.25M | Hold |
79,995
| – | – | 0.23% | 46 |
|
|
2024
Q3 | $6.43M | Hold |
79,995
| – | – | 0.21% | 48 |
|
|
2024
Q2 | $6.62M | Sell |
79,995
-300
| -0.4% | -$26.4K | 0.22% | 48 |
|
|
2024
Q1 | $6.85M | Sell |
80,295
-700
| -0.9% | -$54.9K | 0.22% | 47 |
|
|
2023
Q4 | $6.93M | Hold |
80,995
| – | – | 0.24% | 46 |
|
|
2023
Q3 | $7.26M | Hold |
80,995
| – | – | 0.28% | 47 |
|
|
2023
Q2 | $6.9M | Hold |
80,995
| – | – | 0.24% | 49 |
|
|
2023
Q1 | $6.7M | Hold |
80,995
| – | – | 0.24% | 49 |
|
|
2022
Q4 | $6.37M | Sell |
80,995
-8,000
| -9% | -$643K | 0.25% | 48 |
|
|
2022
Q3 | $6.59M | Sell |
88,995
-9,500
| -10% | -$682K | 0.26% | 49 |
|
|
2022
Q2 | $6.42M | Sell |
98,495
-500
| -0.5% | -$29.6K | 0.24% | 50 |
|
|
2022
Q1 | $6.26M | Sell |
98,995
-13,000
| -12% | -$707K | 0.18% | 51 |
|
|
2021
Q4 | $5.94M | Sell |
111,995
-28,500
| -20% | -$1.74M | 0.15% | 51 |
|
|
2021
Q3 | $9.92M | Sell |
140,495
-10,750
| -7% | -$678K | 0.27% | 50 |
|
|
2021
Q2 | $10.1M | Sell |
151,245
-2,000
| -1% | -$142K | 0.28% | 49 |
|
|
2021
Q1 | $17M | Hold |
153,245
| – | – | 0.51% | 42 |
|
|
2020
Q4 | $18.2M | Sell |
153,245
-900
| -0.6% | -$96.9K | 0.54% | 40 |
|
|
2020
Q3 | $13.4M | Sell |
154,145
-5,000
| -3% | -$437K | 0.49% | 40 |
|
|
2020
Q2 | $14.3M | Hold |
159,145
| – | – | 0.52% | 36 |
|
|
2020
Q1 | $15.9M | Buy |
159,145
+495
| +0.3% | +$53.7K | 0.77% | 31 |
|
|
2019
Q4 | $18.2M | Sell |
158,650
-85
| -0.1% | -$10.3K | 0.76% | 34 |
|
|
2019
Q3 | $20M | Hold |
158,735
| – | – | 0.89% | 35 |
|
|
2019
Q2 | $19.1M | Sell |
158,735
-2,500
| -2% | -$246K | 0.82% | 37 |
|
|
2019
Q1 | $14.1M | Sell |
161,235
-66,765
| -29% | -$6.07M | 0.65% | 39 |
|
|
2018
Q4 | $22.8M | Sell |
228,000
-6,200
| -3% | -$651K | 1.22% | 33 |
|
|
2018
Q3 | $26.8M | Hold |
234,200
| – | – | 1.17% | 31 |
|
|
2018
Q2 | $21M | Sell |
234,200
-8,200
| -3% | -$692K | 1.08% | 32 |
|
|
2018
Q1 | $17.7M | Sell |
242,400
-178,896
| -42% | -$12.3M | 1.01% | 35 |
|
|
2017
Q4 | $24.5M | Sell |
421,296
-6,200
| -1% | -$326K | 1.47% | 28 |
|
|
2017
Q3 | $19.2M | Sell |
427,496
-11,900
| -3% | -$494K | 1.2% | 30 |
|
|
2017
Q2 | $17.4M | Sell |
439,396
-94,400
| -18% | -$3.88M | 1.12% | 32 |
|
|
2017
Q1 | $21.7M | Sell |
533,796
-34,100
| -6% | -$1.33M | 1.53% | 27 |
|
|
2016
Q4 | $22.8M | Sell |
567,896
-4,640
| -0.8% | -$175K | 1.77% | 22 |
|
|
2016
Q3 | $20.7M | Buy |
+572,536
| New | +$19.7M | 1.59% | 23 |
|
|
2016
Q2 | – | Sell |
-699,316
| Closed | -$24.5M | – | 136 |
|
|
2016
Q1 | $24.5M | Sell |
699,316
-4,060
| -0.6% | -$131K | 2.14% | 15 |
|
|
2015
Q4 | $22.7M | Buy |
703,376
+10,920
| +2% | +$354K | 2.01% | 18 |
|
|
2015
Q3 | $22.4M | Buy |
692,456
+19,340
| +3% | +$728K | 2.32% | 15 |
|
|
2015
Q2 | $27.8M | Sell |
673,116
-7,094
| -1% | -$299K | 2.65% | 15 |
|
|
2015
Q1 | $30.6M | Sell |
680,210
-2,286
| -0.3% | -$95.6K | 3.01% | 11 |
|
|
2014
Q4 | $25.5M | Sell |
682,496
-974
| -0.1% | -$35.7K | 2.77% | 13 |
|
|
2014
Q3 | $23.9M | Buy |
683,470
+15,800
| +2% | +$564K | 2.78% | 13 |
|
|
2014
Q2 | $23.6M | Sell |
667,670
-50,710
| -7% | -$1.69M | 2.65% | 14 |
|
|
2014
Q1 | $23.4M | Sell |
718,380
-18,490
| -3% | -$707K | 2.76% | 11 |
|
|
2013
Q4 | $31M | Buy |
736,870
+35,850
| +5% | +$1.48M | 3.85% | 6 |
|
|
2013
Q3 | $28M | Buy |
701,020
+22,800
| +3% | +$957K | 3.75% | 6 |
|
|
2013
Q2 | $28M | Buy |
+678,220
| New | +$27.5M | 4.21% | 3 |
|
Other funds holding HAE
AI
American Capital Management's HAE Position: Q2 2026 in Review
American Capital Management held its Haemonetics (HAE) position steady in Q2 2026 at 66,915 shares worth $5.02M. The position accounts for 0.23% of the portfolio, ranked #50.
American Capital Management first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $31M in Q4 2013. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- American Capital Management held 66,915 shares of Haemonetics worth $5.02M as of Q2 2026.
- American Capital Management left its Haemonetics share count unchanged in Q2 2026.
- Haemonetics made up 0.23% of American Capital Management's portfolio in Q2 2026, its #50 holding.
- American Capital Management first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
- American Capital Management's Haemonetics position peaked at $31M in Q4 2013.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on American Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.